Comparison of Autoimmune Thyroid Disease in Patients With Progressive and Stable Vitiligo

Yazdanpanah, Mohammad Javad; Noghabi, Seyed Ali Seyedi; Taghavi, Morteza; Aghaee, Monavar Afzal; Zabolinejad, Nona

doi:10.1177/1203475415604551

Cited by 5 publications

(14 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This finding suggests that the risk of AITD increases with age. Similar results were obtained by another study that found thyroid disorders to be more common in patients over 30 years of age . Contrary to this, Bae et al .…”

Section: Specific Autoimmune Comorbiditiessupporting

confidence: 87%

“…This finding suggests that the risk of AITD increases with age. Similar results were obtained by another study that found thyroid disorders to be more common in 39 Contrary to this, Bae et al 40 found the association between vitiligo and both Graves' disease and Hashimoto's thyroiditis to be strongest in children and adolescents.…”

Section: Thyroid Diseasesupporting

confidence: 79%

“…Many studies emphasize the difference between the prevalence of thyroid abnormalities in patients with SV and NSV . NSV seems to be more correlated with both autoimmune thyroid disorders and elevated thyroid autoantibodies compared with SV.…”

Section: Specific Autoimmune Comorbiditiesmentioning

confidence: 99%

“…Yazdanpanah et al . evaluated the difference between thyroid disorders in patients with progressive and stable vitiligo.…”

Section: Specific Autoimmune Comorbiditiesmentioning

confidence: 99%

“…21,43 AITD is clinically diagnosed when anti-TPO antibodies are increased. 32,43 The prevalence of elevated anti-TPO antibodies is between 21 and 40% 32,39,42,43 in vitiligo patients.…”

Section: Thyroid Diseasementioning

confidence: 99%

See 4 more Smart Citations

Comorbidities in vitiligo: comprehensive review

2018

View full text Add to dashboard Cite

Vitiligo is a common skin disorder characterized by idiopathic, progressive cutaneous hypomelanosis. Vitiligo is associated with several comorbid autoimmune, systemic, and dermatological diseases, primarily thyroid disease, alopecia areata, diabetes mellitus, pernicious anemia, systemic lupus erythematosus, rheumatoid arthritis, Addison's disease, inflammatory bowel disease, Sjögren's syndrome, dermatomyositis, scleroderma, ocular and audiological abnormalities, psoriasis, and atopic dermatitis. It is essential to increase awareness of these comorbidities in order to improve the disease burden and quality of life of patients with vitiligo. Herein, we review the association with the most frequent comorbidities associated with vitiligo.

show abstract

Section: Specific Autoimmune Comorbiditiessupporting

confidence: 87%

Section: Thyroid Diseasesupporting

confidence: 79%

Section: Specific Autoimmune Comorbiditiesmentioning

confidence: 99%

“…Yazdanpanah et al . evaluated the difference between thyroid disorders in patients with progressive and stable vitiligo.…”

Section: Specific Autoimmune Comorbiditiesmentioning

confidence: 99%

“…21,43 AITD is clinically diagnosed when anti-TPO antibodies are increased. 32,43 The prevalence of elevated anti-TPO antibodies is between 21 and 40% 32,39,42,43 in vitiligo patients.…”

Section: Thyroid Diseasementioning

confidence: 99%

See 3 more Smart Citations

Comorbidities in vitiligo: comprehensive review

2018

View full text Add to dashboard Cite

show abstract

An extensive review of vitiligo-associated conditions

Premkumar,

Bhaskar Kalarani,

Mohammed

et al. 2023

International Journal of Dermatology and Venereology

View full text Add to dashboard Cite

Vitiligo is an autoimmune disorder caused by the destruction of melanocytes in various body regions. Numerous diseases may accompany vitiligo. The prevalence of vitiligo varies among geographical regions and shows no relation to sex or age. However, vitiligo most commonly affects people aged 10 to 30 years. The clinical symptoms of vitiligo include irregular patches on the skin and various diseases associated with this disorder. The present review focuses on the clinical effects and risk factors of vitiligo-associated conditions and the current therapeutics for treating vitiligo. This systematic review was performed based on the PRISMA guidelines and articles published from 2000 to 2023 in several electronic databases (Web of Science, PubMed, PsycINFO, and others). The most clinically significant diseases associated with vitiligo are alopecia areata, autoimmune thyroid disease, Addison's disease, and type 1 diabetes mellitus. No targeted population is specifically prone to vitiligo; it does not affect any particular race or sex. Hence, awareness of the diseases associated with vitiligo is necessary to control them through various medical and surgical treatments with the proper facilities.

show abstract

The prevalence of autoimmune endocrine diseases in vitiligo patients

Трошина

Волнухин

Petrov

et al. 2020

Terapevticheskii arkhiv

View full text Add to dashboard Cite

Vitiligo is a common polygenic autoimmune disease in which the foci of depigmentation are formed on the skin and/or mucous membranes as a result of the death of melanocytes. There are several hypotheses for the pathogenesis of the disease, the leading role among them is played the autoimmune hypothesis. This review summarizes the available literature data on the prevalence and structure of comorbid endocrine autoimmune pathology in vitiligo patients. In most studies conducted in Europe, America and Asia the prevalence of autoimmune thyroid diseases (including autoimmune thyroiditis and Graves disease), diabetes mellitus and autoimmune adrenal insufficiency was higher in vitiligo patients than in the general population. The results of some studies indicate a frequent association of vitiligo with autoimmune polyglandular syndromes. In the structure of comorbid pathology the highest prevalence was in autoimmune thyroid diseases. A number of studies have established a higher prevalence of autoimmune endocrine diseases in women, as well as in nonsegmental vitiligo patients and in cases of family history of vitiligo and/or other autoimmune diseases. In addition, it was shown that the prevalence of endocrine diseases increases with increasing area of depigmentation. The data obtained justify the advisability of conducting a timely examination of vitiligo patients with the aim of early detection of comorbid diseases and the appointment of appropriate treatment. Further studies are needed to investigate the effect of the identified associations on the course of vitiligo and comorbid endocrinopathies, as well as the effectiveness of therapy and the quality of life of patients.

show abstract

Comparison of Autoimmune Thyroid Disease in Patients With Progressive and Stable Vitiligo

Abstract: This study not only confirmed thyroid dysfunction in patients with vitiligo but also showed that there was no difference in thyroid dysfunction and anti-TPO antibody levels in the subgroups of patients with stable or progressive vitiligo.

Cited by 5 publications

References 9 publications

Comorbidities in vitiligo: comprehensive review

Comorbidities in vitiligo: comprehensive review

An extensive review of vitiligo-associated conditions

The prevalence of autoimmune endocrine diseases in vitiligo patients

Contact Info

Product

Resources

About